Australian Clinical Labs Limited (ACL.AU) Q1 2024 Earnings

27FebConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2024
0
0.08
0.16
0.24

Details

Expected EPS
0.0899869651589242
Actual EPS
0.053159929706601466
Surprise EPS
-0.04
Surprise Percent
+40.92%

Description

Australian Clinical Labs Limited (ACL.AU) has reported earnings of 0.053159929706601466 per share for Q1 2024.

0 Comments

Share your thoughts